Supportive Care | Specialty

Second Cancers Can Wield Greater Impact on Adolescent and Young Adult Survivors

June 9th 2017

Advances in treatment and supportive care have resulted in substantial improvements in cancer survival and a growing number of cancer survivors in the United States.

Dr. Attai on the Challenges With Implementing Survivorship Care Plans

June 4th 2017

Deanna J. Attai, MD, assistant clinical professor of surgery at the David Geffen School of Medicine at the University of California Los Angeles (UCLA), breast surgeon at UCLA Health, discusses studies exploring the challenges with survivorship care plan implementation for patients with cancer in an interview during the 2017 ASCO Annual Meeting.

Late Effects of Childhood Cancers Dropping Along With Intensity of Treatments

June 3rd 2017

The rate of severe long-term side effects caused by treatments for childhood cancers is dropping over time, according to findings from a retrospective analysis of 23,600 survivors enrolled in the Childhood Cancer Survivor Study.

European Commission Approves Oral Rolapitant for CINV

April 26th 2017

The European Commission has approved oral rolapitant tablets for the treatment of delayed chemotherapy-induced nausea and vomiting in adults.

FDA Eliminates REMS Requirement for ESAs

April 14th 2017

The FDA has eliminated the need for risk evaluation and mitigation strategy certification prior to the administration of erythropoiesis-stimulating agents for anemia due to myelosuppressive chemotherapy.

FDA Accepts Ibrutinib Application for GVHD

April 5th 2017

The FDA has accepted a supplemental new drug application for ibrutinib as a treatment for patients with chronic graft-versus-host-disease after failure of 1 or more lines of systemic therapy.

Thoughts on Metastatic Kidney Cancer

March 20th 2017

Patient Communication About Adjuvant Therapy for RCC

March 20th 2017

VEGF TKI Therapy in the Adjuvant Setting of RCC

March 20th 2017

Upfront Immunotherapy for Metastatic Kidney Cancer

March 20th 2017

CABOSUN Trial of Upfront Cabozantinib in Metastatic RCC

March 20th 2017

Treatment Beyond Progression for Metastatic RCC

March 20th 2017

Clinical Trials of Post-Progression Therapy for mRCC

March 20th 2017

Metastatic RCC: Decision Trees for Second-Line Therapy

March 20th 2017

Choosing Post-Progression Therapy for Metastatic RCC

March 20th 2017

Defining Progression in Metastatic Kidney Cancer

March 20th 2017

Choosing Frontline Therapy for Metastatic Kidney Cancer

March 20th 2017

Goals of Therapy for Advanced Kidney Cancer

March 20th 2017

Rapidly Evolving Paradigms for Treating Advanced RCC

March 20th 2017

Dr. Levine on Palliative Care for NSCLC

March 7th 2017

Stacie Levine, MD, associate professor of Medicine, director, Geriatrics and Hospice and Palliative Medicine Fellowship Program, University of Chicago Medicine, discusses the benefits of palliative care for patients with non–small cell lung cancer (NSCLC).